Trial
NCT00856661
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
H. Lundbeck A/S
Collaborators
—
Condition
Stroke
Intervention
Desmoteplase
Why stopped
The recruitment into DIAS4 has been stopped as the result of DIAS 3 indicates that the study is unlikely to reach its primary endpoint with the current protocol
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-16